press release – price-sensitive

THE BOARD OF DIRECTORS HAS APPROVED THE HALF-YEARLY REPORT AS OF 30 JUNE 2026

FINANCING AND THE AWARD OF FUNDING FOR THE NEX-BIO PROJECT, WORTH 2 MILLION EUROS

REVENUE AS OF JUNE 30, 2026, AMOUNTING TO APPROXIMATELY 3.0 MILLION EUROS, AN INCREASE OF APPROXIMATELY 17.7% COMPARED TO THE SAME PERIOD IN 2025

TURNOVER AS OF MARCH 31, 2026 EQUAL TO APPROXIMATELY 1.6 MILLION EUROS

SHAREHOLDERS’ MEETING OF ARTERRA BIOSCIENCE S.P.A.

FINANCING AND GRANTING OF FUNDING FOR THE ‘RE-FOOD’ PROJECT IN THE AMOUNT OF €720,000

PUBLICATION OF NOTICE OF CALL FOR ORDINARY SHAREHOLDERS’ MEETING

THE BOARD OF DIRECTORS HAS APPROVED THE DRAFT FINANCIAL STATEMENTS AS OF 31 DECEMBER 2025

TURNOVER AS OF 31 DECEMBER 2025 AMOUNTING TO €4.6 MILLION, AN INCREASE OF 11.42% COMPARED TO THE SAME PERIOD IN 2024

TRANSFER OF SHARES BY MARIA GABRIELLA COLUCCI TO SMART CAPITAL